Swapnali A. Thorat

Swapnali A. Thorat

Auto-generated profile, based on publicly available information

Swapnali A. Thorat

Rajarambapu College of Pharmacy, Kasegaon, Sangli, Maharashtra, 415404, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Current Enzyme Inhibition
Verified
Journal Article
Closed access
PDF file
DNDnyaneshwar T. Nagre
Dnyaneshwar T. Nagre
Suraj N. MaliSuraj N. Mali
Suraj N. Mali
BTBapu R. Thorat
Bapu R. Thorat
STSwapnali A. Thorat
Swapnali A. Thorat
ACAtul R. Chopade
Atul R. Chopade
BABrijmohan Agrawal
Brijmohan Agrawal
Background: The bis(indolyl)methanes (BIMs) scaffold is reported for wide varieties of pharmacological profiles, including antibacterial, anti-proliferative, anticancer, cytotoxic, insecticidal, analgesic, antioxidant, and anti-inflammatory agents. Materials and Methods: A series of bis(indolyl)methanes have been synthesized by a greener and newer approach using the reaction of different substituted aldehydes and indole in the presence of an easily available and biodegradable base such as piperidine in acetic acid at room temperature and characterized with ultraviolet–visible spectrophotometry (UV–Vis or UV/Vis), Fourier-transform infrared spectroscopy (FTIR), nuclear magnetic resonance spectroscopy (NMR), etc. The antibacterial and antifungal activities were also carried out against Staphylococcus aureus (RCMB 000106) and Bacillis subtilis (RCMB 000107), as two Gram-positive bacterial strains, and Salmonella typhi and Escherichia coli (RCMB 000103), as two Gram-negative bacterial strains. Fungal species such as Candida Albicans, Penicillium chrysogenum, Aspergillus niger were also used for in vitro antifungal evaluation. All our newly synthesized 14 compounds (4a-4n) were subjected for anti-inflammatory activity in vitro and compared with the known standard drug aceclofenac. Results: Our newly synthesized compounds showed good to moderate antibacterial agents, in silico ADMET, and anti-inflammatory profiles. Conclusion: We hope that our current study would aid future developments of bis(indolyl)methanes as antibacterial and anti-inflammatory agents.

15 June 2020 in Research Journal of Medicinal Plant
Verified
Journal Article
Closed access
RARahul S. Adnaik
Rahul S. Adnaik
VDVyankatesh R. Dharang
Vyankatesh R. Dharang
STSwapnali A. Thorat
Swapnali A. Thorat
PAPratibha R. Adnaik
Pratibha R. Adnaik
PNPrajakta D. Nayakal
Prajakta D. Nayakal
SPSanket S. Patil
Sanket S. Patil
In-silico Evaluation of Wound Healing Potential of Euphorbia tithymaloides

30 May 2026 in Journal of Natural Remedies
Verified
Journal Article
Open access
SPSangram Subhash Patil
Sangram Subhash Patil
KBKishor B. Burade
Kishor B. Burade
SDSwapnali V. Dharanguttikar
Swapnali V. Dharanguttikar
GWGanesh H. Wadkar
Ganesh H. Wadkar
SMSangram S. Madane
Sangram S. Madane
PPPrajakta S. Patil
Prajakta S. Patil
Background: Cancer continues to be a global health problem today. Traditional chemotherapy, which is commonly used in the treatment of cancer, has problems like low bioavailability, systemic toxicity, and drug resistance. Polyherbal formulations provide synergistic therapeutic advantages, whereas phyto-phospholipid complexation improves the solubility, permeability, and bioavailability of phytoconstituents. Aim: To develop and evaluate phyto-phospholipid complexes from a specific polyherbal churna extract that includes Picrorhiza kurroa, Bauhinia variegata, and Curcuma longa to boost their anticancer effects. Methods: A hydroalcoholic extract of polyherbal churna was prepared by maceration. Phyto-phospholipid complexes were prepared using the solvent evaporation method at different drug-phospholipid ratios (1:1, 1:2, and 1:3). Particle size analysis, Fourier Transform Infrared Spectroscopy (FTIR), X-Ray Diffraction (XRD), Digital Signature Certificate (DSC), and zeta potential determination were used to characterise the optimised complex. The DPPH and ABTS tests were used to see how well the antioxidants worked. The MTT assay was used to assess how toxic the cells were to HeLa, MCF-7, and A549 cancer cell lines. Results: Enhanced solubility and entrapment efficiency of 78.45 ± 2.3% were demonstrated by the optimised phyto-phospholipid complex (1:2 ratios). Complex formation was verified by FTIR and DSC. With IC50 values of 24.8 ± 1.5 μg/mL (DPPH) and 28.3 ± 1.8 μg/mL (ABTS), the complex outperformed crude extract in terms of antioxidant activity (IC50: 45.2 ± 2.1 and 52.6 ± 2.4 μg/mL, respectively). Comparing the complex to crude extract, cytotoxicity studies showed significantly lower IC50 values against MCF-7 (32.5 ± 2.1 μg/mL), HeLa (38.7 ± 2.5 μg/mL), and A549 (42.3 ± 2.8 μg/mL). Conclusion: Polyherbal churna extract phyto-phospholipid complexes showed increased antioxidant and cytotoxic potential, suggesting potential for cancer treatment and calling for additional in vivo research. Major Findings: The optimized complex (1:2 ratio) showed 5-fold enhanced solubility, 45% stronger antioxidant activity (IC₅₀: 24.8 vs 45.2 μg/mL), and two-fold improved cytotoxicity against cancer cell lines (IC₅₀: 32.5-42.3 vs 68.5-82.7 μg/mL) compared to crude extract, as confirmed by comprehensive characterization (FTIR, DSC, XRD, SEM, TEM).